Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Induction of Immunogenicity With Different Doses of Grass MATA in Subjects Allergic to Grass and Rye Pollen

ClinicalTrials.gov ID: NCT00104377

Public ClinicalTrials.gov record NCT00104377. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 3:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Single-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Induction of Immunogenicity With Different Doses of Grass MATA in Subjects Allergic to Grass and Rye Pollen

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Grass MATA (modified pollen allergen tyrosine adsorbate) has been developed to provide pre-seasonal specific immunotherapy for patients with hypersensitivity to grass and rye pollen. Different doses of Grass MATA will be administered and immunological changes following this treatment will be assessed.

Study identification

NCT ID
NCT00104377
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Allergy Therapeutics
Industry
Enrollment
70 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years to 50 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2005 (Type not available)
Primary completion
Not listed
Completion
Nov 2005 (Type not available)
Last update posted
Jun 17, 2010

2005

United States locations

U.S. sites
11
U.S. states
9
U.S. cities
11
Facility City State ZIP Site status
College Park Family Care Center Multi-Specialty Clinical Research Overland Park Kansas 66210 —
Northeast Medical Research Associates North Dartmouth Massachusetts 02747 —
Midwest Clinical research, LLC St Louis Missouri 63141 —
Allergy, Asthma, and Immunology Assoc. PC Lincoln Nebraska 68505 —
Asthma, Sinus, and Allergy Centers, LLC Tinton Falls New Jersey 07701 —
Bernstein Clinical Research Center, LLC Cincinnati Ohio 45231 —
Clinical Research Institute of Southern Oregon, PC Medford Oregon 97504 —
Allergy Associates Research Center Portland Oregon 97213 —
Allergy and Clinical Immunology Associates Pittsburgh Pennsylvania 15241 —
Asthma and Allergy Research Associates Upland Pennsylvania 19013 —
Sylvana Research Associates San Antonio Texas 78229 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00104377, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 17, 2010 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00104377 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →